Dantrolene inhibits human erythrocyte glutathione reductase

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 11, 2008, Pages 2036-2039

  Şentürk, Murat ^a   Gülçin, Ilhami ^a   Çiftci, Mehmet ^a   Küfrevioǧlu, Ömer Irfan ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Dantrolene; Enzyme purification; Glutathione reductase; Human erythrocyte; Inhibition

Indexed keywords

DANTROLENE; FLAVOPROTEIN; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; PYRIDINE NUCLEOTIDE; SEPHADEX; SEPHAROSE;

AFFINITY CHROMATOGRAPHY; ARTICLE; CALCIUM TRANSPORT; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; GEL CHROMATOGRAPHY; GEL FILTRATION CHROMATOGRAPHY; HEMOLYSATE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALIGNANT HYPERTHERMIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PURIFICATION; SARCOPLASMIC RETICULUM; SPECTROPHOTOMETRY; TEMPERATURE;

CELLS, CULTURED; CHROMATOGRAPHY, AGAROSE; DANTROLENE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; ERYTHROCYTES; GLUTATHIONE REDUCTASE; HUMANS; MUSCLE RELAXANTS, CENTRAL;

EID: 55549088586     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2036     Document Type: Article

References (37)

1. Carlberg I., Mannervik B., J. Biol. Chem., 250, 5475-5480 (1975).
2. Kaplowitz N., Aw T. Y., Ookhtens M., Annu. Rev. Pharmacol. Toxicol., 25, 715-744 (1985).
3. Black S. M., Wolf C. R., Pharmacol. Ther., 51, 139-154 (1991).
4. Meisler A., Anderson M. E., Ann. Rev. Biochem., 52, 711-760 (1983).
5. Gül M., Kutay F. Z., Temocin S., Hanninen O., Indian J. Exp. Biol., 38, 625-634 (2000).
6. Champe P. C., Harvey R. A., Ferrier D. R., "Biochemistry," 4 ed., Lippincott Williams and Wilkins, Baltimore, 2008.
7. Schirmer R. H., Krauth-Siegel R. L., Schulz G. E., "Glutathione Reductase," John Wiley and Sons, New York, 1989, pp. 553-596.
8. Akerlund B., Tynell E., Bratt G., Bielenstein M., Lidman C., J. Infect., 35, 143-147 (1997).
9. Jenner P., Olanow C. W., Ann. Neurol., 44, 72-84 (1998).
10. Vijayalingam S., Parthiban A., Shanmugasundaram K. R., Mohan V., Diabet. Med., 13, 715-719 (1996).
11. Yoshida K., Hirokawa J., Tagami S., Kawakami Y., Urata Y., Kondo T., Diabetologia, 38, 201-210 (1995).
12. Srivastava S. K., Beutler E., Biochem. J., 119, 353-357 (1970).
13. Thieme R. R., Pai E. F., Schirmer R. H., Schulz G. E., J. Mol. Biol., 152, 763-782 (1981).
14. Boggaram V., Brobjer T., Larson K., Mannervik B., Anal. Biochem., 98, 335-340 (1979).
15. Büyükokuroǧlu M. E., Gülçin İ., Oktay M., Küfrevioǧlu Ö. İ., Pharmacol. Res., 44, 491-494 (2001).
16. Gülçin İ., Beydemir Ş., Büyü kokuroǧlu M. E., Biol. Pharm. Bull., 27, 613-616 (2004).
17. Taylor P., "Goodman and Gilman's the Pharmacological Basis of Therapeutics," ed. by Hardman J. G., Limbird L. E., McGraw Hill, U.S.A., 2001, pp. 193-213.
18. Nasu T., Oosako H., Gen. Pharmacol., 26, 1591-1596 (1995).
19. Erat M., Çiftci M., Eur. J. Pharmacol., 537, 59-63 (2006).
20. Senturk M., Kufrevioglu O. I., Çiftci M., J. Enzym. Inhib. Med. Chem., 23, 144-148. (2008).
21. Beutler E., "Red Cell Metabolism. A Manual of Biochemical Methods 12," Academic Press, London, 1971, pp. 68-70.
22. Bradford M. M., Anal. Biochem., 72, 248-254 (1976).
23. Beydemir Ş., Gülçin İ., J. Enzym. Inhib. Med. Chem., 19, 193-197 (2004).
24. Çoban T. A., Beydemir Ş., Gülçin İ., Ekinci D., Biol. Pharm. Bull., 30, 2257-2261 (2007).
25. Laemmli U. K., Nature (London), 227, 680-685 (1970).
26. Hisar O., Beydemir Ş., Gülçin İ., Aras Hisar Ş., Yanik T., Küfrevioǧlu Ö. İ., Turk. J. Vet. Anim. Sci., 29, 841-845 (2005).
27. Lineweaver H., Burk D., J. Am. Chem. Soc., 56, 658-666 (1934).
28. Kayaalp S. O., "Rasyonal Tedavi Yönünden Tibbi Farmakoloji," Hacettepe-Tas Yayincilik, Ankara (in Turkish), 2002.
29. Pleuvry B. J., Anaesth. Intens. Care Med., 7, 104-106 (2006).
30. Beydemir Ş., Gülçin İ., Küfrevioǧlu Ö. İ., Çiftçi M., Pol. J. Pharmacol., 55, 787-792 (2003).
31. McCallum M. J., Barrett J., Int. J. Biochem. Cell Biol., 27, 393-401 (1995).
32. Erat M., Çiftci M., Gümüştekin K., Gül M., Eur. J. Pharmacol., 554, 92-97 (2007).
33. Zhang K., Yang E. B., Tang W. Y., Wong K. P., Mack P., Biochem. Pharmacol., 54, 1047-1053 (1997).
34. Grellier P., Sarlauskas J., Anusevicius Z., Maroziene A., Houee-Levin C., Schrevel J., Cenas N., Arch. Biochem. Biophys., 393, 199-206 (2001).
35. Bharath S., Hsu M., Kaur D., Rajagopalan S., Andersen J. K., Biochem. Pharmacol., 64, 1037-1048 (2002).
36. Rodríguez V. M., Del Razo L. M., Limón-Pacheco J. H., Giordano M., Sánchez-Peña L. C., Uribe-Querol E., Gutiérrez-Ospina G., Gonsebatt M. E., Toxicol. Sci., 84, 157-166 (2005).
37. Schulz J. B., Lindenau J., Seyfried J., Dichgans J., Eur. J. Biochem., 267, 4904-4911 (2000).